These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22708271)

  • 21. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine.
    Denys D; Klompmakers AA; Westenberg HG
    Psychopharmacology (Berl); 2004 Nov; 176(2):195-203. PubMed ID: 15138756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2002 Mar; 439(1-3):93-100. PubMed ID: 11937097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivity of 5-HT1A receptor in adult rats after neonatal noradrenergic neurons' lesion--implications for antidepressant-like action.
    Dabrowska J; Nowak P; Brus R
    Brain Res; 2008 Nov; 1239():66-76. PubMed ID: 18789911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key role of the 5-HT1A receptor addressing protein Yif1B in serotonin neurotransmission and SSRI treatment.
    Martin V; Mathieu L; Diaz J; Salman H; Alterio J; Chevarin C; Lanfumey L; Hamon M; Austin MC; Darmon M; Stockmeier CA; Masson J
    J Psychiatry Neurosci; 2020 Sep; 45(5):344-355. PubMed ID: 32459080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors.
    Bortolozzi A; Masana M; Díaz-Mataix L; Cortés R; Scorza MC; Gingrich JA; Toth M; Artigas F
    Int J Neuropsychopharmacol; 2010 Nov; 13(10):1299-314. PubMed ID: 20158933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
    Nakayama K; Sakurai T; Katsu H
    Brain Res Bull; 2004 Apr; 63(3):237-41. PubMed ID: 15145142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.
    Invernizzi RW; Sacchetti G; Parini S; Acconcia S; Samanin R
    Br J Pharmacol; 2003 Aug; 139(7):1281-8. PubMed ID: 12890707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice.
    Miura H; Qiao H; Kitagami T; Ohta T; Ozaki N
    Psychopharmacology (Berl); 2005 Jan; 177(3):307-14. PubMed ID: 15290002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2004 Sep; 18(3):395-403. PubMed ID: 15358984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychopharmacology of combined activation of the serotonin
    Ago Y; Hasebe S; Hiramatsu N; Hashimoto H; Takuma K; Matsuda T
    Eur J Pharmacol; 2017 Aug; 809():172-177. PubMed ID: 28529139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
    Li XM; Perry KW; Wong DT
    Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
    Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.
    Zhang W; Perry KW; Wong DT; Potts BD; Bao J; Tollefson GD; Bymaster FP
    Neuropsychopharmacology; 2000 Sep; 23(3):250-62. PubMed ID: 10942849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions.
    Ferrés-Coy A; Santana N; Castañé A; Cortés R; Carmona MC; Toth M; Montefeltro A; Artigas F; Bortolozzi A
    Psychopharmacology (Berl); 2013 Jan; 225(1):61-74. PubMed ID: 22820867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex.
    Huang M; Ichiwaka J; Li Z; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2006 Apr; 185(3):274-81. PubMed ID: 16521036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex.
    Matsumoto M; Togashi H; Mori K; Ueno K; Miyamoto A; Yoshioka M
    Eur J Pharmacol; 1999 Oct; 383(1):39-48. PubMed ID: 10556679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.
    Johansson D; Falk A; Marcus MM; Svensson TH
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):143-8. PubMed ID: 22691715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.